Navigation Links
ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders
Date:9/6/2010

-->
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, Clinical Trials & Medical Discoveries Click to view news release full screen  

ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders

 

LEUVEN, Belgium, September 6, 2010 /PRNewswire-FirstCall/ --

- Data Pre
'/>"/>

SOURCE ThromboGenics NV
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)
2. ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin
3. ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease
4. ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF)
5. ThromboGenics Completes Patient Enrolment for Phase II Trial of Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME)
6. ThromboGenics Microplasmin Phase III Program Progressing According to Schedule
7. ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402
8. ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease
9. ThromboGenics and BioInvent Complete Patient Recruitment of Phase II DVT Prophylaxis Study With Anti-Factor VIII (TB-402)
10. ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease
11. ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015 Mike Rowe , ... at Good Neighbor Pharmacy,s 2015 ThoughtSpot ... 1 in Las Vegas, Nev. ... "Somebody,s Gotta Do It," and Discovery Channel,s, "Dirty Jobs," Mr. ... the nation,s  "unsung heroes" – people whose hard work, sacrifice ...
(Date:7/28/2015)... LEXINGTON, Mass. , July 28, 2015  Today, ... System. A compact, affordable and efficient instrument, with a ... will bring significant benefits to the physicians, office or ... throughput of up to 580 tests/hour with ISE, 72 ... (13L/day) and has 36 onboard assays (+3 ISE) to ...
(Date:7/28/2015)... ROCHESTER, N.Y. , July 28, 2015 ... of clinical trial imaging solutions, today announced that it ... the 4:00 p.m. ET market close on Tuesday, August ... chief executive officer, and Jim Groff , chief ... to discuss the company,s financial results and provide a ...
Breaking Medicine Technology:Mike Rowe to Address Community Pharmacists at ThoughtSpot 2015 2Sekisui Diagnostics Announces Launch of SK500 Clinical Chemistry System for US Laboratories 2VirtualScopics, Inc. Schedules Second Quarter 2015 Financial Results Press Release, Conference Call And Webcast 2VirtualScopics, Inc. Schedules Second Quarter 2015 Financial Results Press Release, Conference Call And Webcast 3
... in 40 Countries ... ... May 27, Shire Limited (LSE: SHP, NASDAQ: SHPGY), the,global specialty ... for the treatment of,Hunter syndrome, has been approved by the ...
... at the,West Virginia University School of Medicine have ... of nutrients in patients with,inflammatory bowel disease (IBD), ... Diseases at WVU., "The most important step ... treating this chronic condition is to find out ...
Cached Medicine Technology:Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 2Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 4Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 5Research Team Clones Genes Responsible for Amino Acid Absorption 2
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... Dr. Aziz ... , The talk took place from noon to 1 p.m. Tuesday, June 23, at ... City, Fla. , Dr. Ahmad is board-certified in colorectal surgery and has more ...
(Date:7/28/2015)... ... July 28, 2015 , ... OrthAlign, ... of its ORTHALIGN PLUS® system, a palm-sized, single-use navigation device for Total Hip ... combined precision with practicality in a revolutionary way for Total Knee Arthroplasty surgeries ...
(Date:7/28/2015)... ... 2015 , ... Healthpointe ’s Cosmetic Laser Institute in Anaheim is now ... and reduces the appearance of fine lines and wrinkles. , According to the Allergan ... add volume to your cheek area to correct age-related volume loss in adults over ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... BMI of ... now offering the duodenal switch weight loss surgery procedure. Committed to helping ... bariatric surgery procedures, BMI of Texas is one of the first practices ...
(Date:7/28/2015)... ... 28, 2015 , ... According to WFTV on July 15th heroin ... heroin toxicity cases. According to recent statistic Orlando suffers at least one death weekly ... hub of heroin, and law enforcement officials are struggling to keep apace with its ...
Breaking Medicine News(10 mins):Health News:Dr. Aziz Ahmad Delivers Talk at Gulf Coast Medical Center 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 3Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 2Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 3Health News:BMI of Texas Now Offering Duodenal Switch Surgery – Weight Loss Procedure Helps Obese Patients Lose Weight Quickly 2Health News:BMI of Texas Now Offering Duodenal Switch Surgery – Weight Loss Procedure Helps Obese Patients Lose Weight Quickly 3Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 2Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 3
... new discovery may lead to more effective screening and treatment ... tumor-like growths and a high risk of developing specific cancers. ... issue of the American Journal of Human Genetics, ... alternate susceptibility gene for Cowden syndrome (CS) and related disorders. ...
... MRIs to skyrocket over the next five ... years, according to Millennium Research Group, WALTHAM, ... US Markets for Women,s Health Imaging Systems 2008 report,the ... magnetic,resonance imaging (MRI) coils, dedicated breast MRI systems, and,breast-specific ...
... of Diabetes Educators (AADE) today announced results from ... between people with diabetes that require insulin injections ... results, 33 percent of respondents have experienced some ... percent strongly agreed/25 percent somewhat agreed), 14 percent ...
... Research Laboratories,Inc. (CRL) announced today that it has ... follow-up libraries. Such ultra-fast,hit-to-lead libraries are now produced ... three to six days which enables critical acceleration ... new industry benchmark.,This state-of-the-art high-throughput chemistry technology was ...
... Benefit Services, Inc., today announced the release of their 2008 Benefit ... trends and strategies. , ... Syosset, NY (PRWEB) August ... Inc., today announced the release of their 2008 Benefit Plan Report, ...
... The CDC,s revised statistics regarding new HIV infections emphasizes the critical ... Startling statistics show 25% of persons infected don,t know they carry ... ... New cases of HIV infection in the U.S. have been underestimated ...
Cached Medicine News:Health News:Beyond PTEN: Alternate genes linked to breast, thyroid and kidney cancer predisposition 2Health News:Adjunct Breast Imaging Market to Increase by Almost 28% per Year Through 2013 2Health News:New survey explores the impact of insulin injections on people with diabetes 2Health News:New survey explores the impact of insulin injections on people with diabetes 3Health News:New survey explores the impact of insulin injections on people with diabetes 4Health News:ChemBridge Research Laboratories, Inc. (CRL) has Established an Industry Record and Benchmark in Hit-to-Lead Libraries Turn-around Time 2Health News:Average Annual Medical Premium Costs Increased 6%, Says 2008 Benefit Plan Report from C&B Consulting 2Health News:Why Affordable HIV Testing Is More Important Than Ever: "HIV Epidemic 40% Higher Than Estimates" 2Health News:Why Affordable HIV Testing Is More Important Than Ever: "HIV Epidemic 40% Higher Than Estimates" 3
Maxi XL Hybridization Oven for Extra Large bottles. 6 bottle (70 mm) rotisserie + shaker tray available for simultaneous use. Includes linear and orbital shaker trays, 4 extra large bottles, pack o...
Inquire...
... ,Smaller slot surface area results in increased signal. ... slot dimensions require less sample than dot-blotters. , ... generated with the slot-blotter allows you to visualize ... types of transfer membranes ,Allows you ...
... The Minifold I system consists of four basic ... plenum, and metal clamping plate (see diagram). The ... for producing spots, dots, or slots (see below). ... purchased as an accessory plate in conjunction with ...
Medicine Products: